Cite

HARVARD Citation

    Chajon, E. et al. (n.d.). OC-0281 Phase I/II trial of hafnium oxide nanoparticles activated by SBRT in the treatment of liver cancers. Radiotherapy and oncology. pp. S139-. [Online]. 
  
Back to record